Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-01-31
2011-11-08
Kapushoc, Stephen (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
08053182
ABSTRACT:
The present invention provides methods and kits for predicting transplant rejection or tolerance. Methods for predicting the probability of cardiac allograft rejection via profiling of peripheral blood gene expression are also provided.
REFERENCES:
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2004/0009479 (2004-01-01), Wohlgemuth et al.
patent: WO 9915700 (1999-04-01), None
patent: WO 01/81916 (2001-11-01), None
Cheung V.G. et al. Nature Genetics (Mar. 2003), vol. 33, p. 422-425.
Baan C.C. et al. Clin Exp. Immunol. (1994) vol. 97, p. 293-298.
Hoshikawa Y. et al. Physiol. Genomics (2003) vol. 12, p. 209-219.
Perren Cobb J. et al. Crit Care Med (2002) vol. 30, No. 12, p. 2711-2721.
Juppner H. Bone (Aug. 1995) vol. 17, No. 2, Supplement, p. 39S-42S.
Whitney A.R. et al. PNAS (Feb. 2003), vol. 100, No. 4, p. 1896-1901.
Flechner S.M. et al. American Journal of Transplantation (2004) vol. 4, p. 1475-1489.
Billingham ME. et al “A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group”. The International Society for Heart Transplantation. J Heart Transplant. 1990;9:587-93.
Pophal SG. et al “Complications of endomyocardial biopsy in children” J Am Coll Cardiol. 1999;34:2105-10.
de Groot-Kruseman HA et al, “Intragraft interleukin 2 mRNA expression during acute cellular rejection and left ventricular total wall thickness after heart transplantation”. Heart. 2002;87:363-7.
Shulzhenko N. et al “Monitoring of intragraft and peripheral blood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans”. Hum Immunol. 2001;62:342-7.
Shulzhenko N. et al “Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation”. Transplantation. 2001;72:1705-8.
Shulzhenko N, et al “Expression of CD40 ligand, interferon-gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts: correlation with acute rejection”. Braz J Med Biol Res. 2001;34:779-84.
van Emmerik N. et al “Cytokine gene expression profiles in human endomyocardial biopsy (EMB) derived lymphocyte cultures and in EMB tissue”. Transpl Int. 1994;7 Suppl 1:S623-6.
Alpert S, Lewis NP et al “The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction”. Transplantation. 1995;60:1478-85.
Baan CC et al “Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants”. Clin Exp Immunol. 1994;97:293-8.
Kobashigawa JA. “Treatment of nonhemodynamic compromising rejection: conventional approaches vs individualization
ew immunosuppressive drugs”. Transplant Proc. 1997;29:37S-39S.
Li C, et al. “Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection”. 2001;98:31-36.
Seo J, et al. “Optimizing signal
oise ratios in expression profiling: project-specific algorithm selection and detection p value weighting in affymetrix microarrays”. Bioinformatics. 2004.
Irizarry RA, et al “Speed TP. Exploration, Normalization, and Summaries of High Density Oligonucleotide Array Probe Level Data Biostatistics”. 2003;4:249-264.
Wu Z, et al “Preprocessing of oligonucleotide array data”. Nat Biotechnol. 2004;22:656-8.
Ihake R et al “A Language for Data Analysis and Graphics. Journal of Graphical and Computational Statistics”. 1996;5:299-314.
Tusher VG et al “Significance analysis of microarrays applied to the ionizing radiation response”. Proc Natl Acad Sci U S A. 2001;98:5116-21.
Eisen MB et al “Cluster analysis and display of genome-wide expression patterns”. 1998;95:14863-14868.
Kimball PM et al “The paradox of cytokine monitoring-predictor of immunologic activity as well as immunologic silence following cardiac transplantation”. Transplantation. 1996;61:909-15.
Lagoo AS et al, “Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients”. Journal of Heart & Lung Transplantation. 1996;15:206-17.
Morgun A et al “Cytokine and TIRC7 mRNA expression during acute rejection in cardiac allograft recipients”. Transplant Proc. 2001;33:1610-1.
Valk PJ et al “Prognostically useful gene-expression profiles in acute myeloid leukemia”. N Engl J Med. 2004;350:1617-28.
Bullinger L et al “Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia”. N Engl J Med. 2004;350:1605-16.
Rosenwald A et al, “The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma”. N Engl J Med. 2002;346:1937-47.
Sarwal M et al, “Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling”. N Engl J Med. 2003;349:125-38.
Inohara N et al, “CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis”. Proc Natl Acad Sci U S A. 1997;94:10717-22.
Expression profiling—best practices for data generation and interpretation in clinical trials. The Tumor Analysis Best Practices Working Group. Nat Rev Genet. 2004;5:229-37.
Baechler EC et al, “Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation”. Genes Immun. 2004.
Guerette B et al “Increased granzyme B mRNA after alloincompatible myoblast transplantation” Transplantation, Williams and Wilkins, Baltimore, MD US., vol. 60, No. 9, Nov. 15, 1995 (pp. 1011-1016.
Tewari, M. et al “Lymphoid expression and regulation of A20, an inhibitor of programmed call death” J. Immunol., vo. 154, No. 4 1995, pp. 1699-1706.
Clement, M.V. et al “Perforin and granzyme B expression is associated with sever acute rejection” Transplantation, vol., 57 No. 3, 1994, pp. 322-326.
Strehlau J., et al “Quantificative detection of immune activation transcripts as a diagnostic tool in kidney transplantation” Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, US, vol. 94, 1997, pp. 695-700.
Griffiths G M et al Granzyme A and perforin as markers for rejection in cardiac transplantation: European Journal of Immunology, Weinheim, de, vol. 21, 1991, pp. 687-692.
Lipman M.L. et al “Heightened intragraft cytotoxic T lypmphocyte gene expression in acutely rejecting renal allografts” J. Immunol., vol. 152, 1994, pp. 5120-5127.
Soares, M.P. et al “Expression of heme oxygenase-1 can determine cardiac xenograft survival” Mat. Med., vol. 4, No. 9, Sep. 1998, pp. 1073-1077.
Cappola Thomas
Epstein Jonathan A.
Cohen Mark S.
Kapushoc Stephen
Pearl Cohen Zedek Latzer LLP
The Trustees of the University of Pennsylvania
LandOfFree
Predictors of transplant rejection determined by peripheral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Predictors of transplant rejection determined by peripheral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predictors of transplant rejection determined by peripheral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4294965